What is BofA Securities's price target for PRTA?

BofA Securities's latest stated price target for Prothena Corporation plc (PRTA) is $4, from its action on May 28, 2025.

What is BofA Securities's rating on PRTA?

BofA Securities rates PRTA Underperform, a bearish rating, as of May 28, 2025.

When did BofA Securities last change its view on PRTA?

On May 28, 2025, BofA Securities downgrades to Underperform from Neutral, price target $4.

Analyst firms · BofA Securities · PRTA

BofA Securities PRTA price target and rating history

Prothena Corporation plc (PRTA) · Health Care

BofA Securities rates Prothena Corporation plc (PRTA) Underperform with a $4 price target, as of its latest action on May 28, 2025. It has published 3 rating actions on PRTA since September 2022, including 1 upgrade and 2 downgrades.

Current rating: Underperform
Price target: $4
Median target, all firms: Too few
Actions on PRTA: 3

BofA Securities price target on PRTA

BofA Securities price target on PRTA, each point a stated target, January 2024 to May 2025.

Every BofA Securities rating on PRTA

May 28, 2025
DowngradeBofA Securities downgrades to Underperform from Neutral, price target $4
Jan 30, 2024
DowngradeBofA Securities downgrades to Neutral from Buy, price target $68 to $38
Sep 28, 2022
UpgradeBofA Securities upgrades to Buy from Neutral

Questions about BofA Securities and PRTA

What is BofA Securities's price target for PRTA?: BofA Securities's latest stated price target for Prothena Corporation plc (PRTA) is $4, from its action on May 28, 2025.
What is BofA Securities's rating on PRTA?: BofA Securities rates PRTA Underperform, a bearish rating, as of May 28, 2025.
When did BofA Securities last change its view on PRTA?: On May 28, 2025, BofA Securities downgrades to Underperform from Neutral, price target $4.

More PRTA rating histories

All BofA Securities ratings PRTA news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.